Finasteride Topical Delivery Systems for Androgenetic Alopecia

被引:21
|
作者
Khan, Muhammad Z. U. [1 ]
Khan, Shujaat A. [1 ]
Ubaid, Muhammad [1 ]
Shah, Aamna [1 ]
Kousar, Rozina [1 ]
Murtaza, Ghulam [1 ]
机构
[1] COMSATS Inst Informat Technol, Dept Pharm, Abbottabad, Pakistan
关键词
Androgenetic alopecia; Finasteride; 5 alpha-reductase isoenzymes; Erectile dysfunction; Topical formulation; Propylene glycol; Flux; LIQUID-CRYSTALLINE NANOPARTICLES; IN-VITRO EVALUATION; PERCUTANEOUS-ABSORPTION; PROPYLENE-GLYCOL; SKIN PENETRATION; RECTAL ABSORPTION; STRATUM-CORNEUM; DRUG-DELIVERY; RAT SKIN; TRANSDERMAL PERMEATION;
D O I
10.2174/1567201815666180124112905
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Androgenetic alopecia, generally recognized as male pattern baldness, is a gradually developing medical and physiological change, which is manifested by continuous hair-loss from scalp. Finasteride (4-aza-3-oxosteroid) is a potent anti-baldness compound that selectively and competitively inhibits the 5 alpha-reductase isoenzymes. Prolonged oral use of finasteride leads to the emergence of sexual disorders including decrease in libido, gynecomastia, erectile dysfunction, ejaculation disorder, orgasm disorders and mood disturbances. Since, hair follicles widely home in 5 alpha-reductase, topical formulations of finasteride in comparison to its oral formulations are expected to potentially reduce its systemic adverse effects. The analysis of literature has revealed some delivery systems developed for the enhanced and localized penetration of finasteride into the skin. These finasteride delivery systems include polymersomes, vesicular nanocarriers, vesicular ethosomal carriers, liposomes and niosomes, liquid crystalline nanoparticles, topical solutions and gels. The aim of this review article is to briefly amass all literature on topical delivery of finasteride to elaborate best dosage form, i.e. formulation having maximum permeation rate. This study will serve as a future perspective regarding topical delivery of finasteride. The literature analysis has exhibited that most of the previous investigators have used propylene glycol in their finasteride-loaded topical formulations, while poloxamer P407, monoolein, transcutol P and choline was used in few formulations. Moreover, among all drug delivery systems, finasteride liposomal gel system consisting of 2% methyl cellulose and gel system containing poloxamer P407 exhibited the highest flux with a value of 28.4 +/- 1.3 mu g/cm(2)h and 23.1 +/- 1.4 mu g/cm(2)h, respectively. Several topical drug delivery techniques such as topical microneedles, aerosol foams, nanoemulsions, microsponges, and emulsifier free formulations, fullerenes, ointments, pastes, creams, gel and lotions are still to be worthy regarding finasteride topical delivery in future.
引用
收藏
页码:1100 / 1111
页数:12
相关论文
共 50 条
  • [31] Topical finasteride for the treatment of male androgenetic alopecia and female pattern hair loss: a review of the current literature
    Suchonwanit, Poonkiat
    Iamsumang, Wimolsiri
    Leerunyakul, Kanchana
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (02) : 643 - 648
  • [32] Effects of a novel finasteride 0.25% topical solution on scalp and serum dihydrotestosterone in healthy men with androgenetic alopecia
    Caserini, Maurizio
    Radicioni, Milko
    Leuratti, Chiara
    Terragni, Emanuela
    Iorizzo, Matilde
    Palmieri, Renata
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2016, 54 (01) : 19 - 27
  • [33] TOPICAL MINOXIDIL IN EARLY ANDROGENETIC ALOPECIA
    KREINDLER, TG
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1987, 16 (03) : 718 - 724
  • [34] ANDROGENETIC ALOPECIA TREATED WITH TOPICAL MINOXIDIL
    DEVILLEZ, RL
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1987, 16 (03) : 669 - 672
  • [35] Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia
    Gupta, Aditya K.
    Talukder, Mesbah
    Williams, Greg
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (07) : 2946 - 2962
  • [36] Oral finasteride improved the quality of life of androgenetic alopecia patients
    Yamazaki, Masashi
    Miyakura, Takashi
    Uchiyama, Masaki
    Hobo, Ayako
    Irisawa, Ryokichi
    Tsuboi, Ryoji
    [J]. JOURNAL OF DERMATOLOGY, 2011, 38 (08): : 773 - 777
  • [37] Finasteride in the treatment of men with androgenetic alopecia using a phototrichogram technique
    Van Neste, D
    Fuh, V
    Sanchez-Pedreno, P
    Lopez-Bran, E
    Wolff, H
    Whiting, D
    Roberts, J
    Stene, JJ
    Tosti, A
    Calvieri, S
    Kopera, D
    Guarrera, M
    Prens, E
    Kanojia, P
    He, W
    Kaufman, KD
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 112 (04) : 653 - 653
  • [38] Dyslipidemia in patients with androgenetic alopecia. Statins, finasteride or both?
    Rudnicka, L.
    Rakowska, A.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (06) : 921 - 922
  • [39] Efficacy and Safety of Finasteride Therapy for Androgenetic Alopecia A Systematic Review
    Manuel Mella, Jose
    Clara Perret, Maria
    Manzotti, Matias
    Norberto Catalano, Hugo
    Guyatt, Gordon
    [J]. ARCHIVES OF DERMATOLOGY, 2010, 146 (10) : 1141 - 1150
  • [40] Depression circumstantially related to the administration of finasteride for androgenetic alopecia - Reply
    Capella, GL
    Altomare, G
    [J]. JOURNAL OF DERMATOLOGY, 2003, 30 (11): : 840 - 844